Syndax Pharmaceuticals Inc
NASDAQ:SNDX

Watchlist Manager
Syndax Pharmaceuticals Inc Logo
Syndax Pharmaceuticals Inc
NASDAQ:SNDX
Watchlist
Price: 20.88 USD 2.5%
Market Cap: 1.8B USD

Intrinsic Value

The intrinsic value of one SNDX stock under the Base Case scenario is 27.5 USD. Compared to the current market price of 20.88 USD, Syndax Pharmaceuticals Inc is Undervalued by 24%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

SNDX Intrinsic Value
27.5 USD
Undervaluation 24%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation History
Syndax Pharmaceuticals Inc

What is Valuation History?
Ask AI Assistant
What other research platforms think about SNDX?

Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.

Discover External Valuations
Why is SNDX valued this way?

Let our AI break down the key assumptions behind the intrinsic value calculation for Syndax Pharmaceuticals Inc.

Explain Valuation
Compare SNDX to

Fundamental Analysis

Company Overview
Loading...
Business Segments
Loading...
Economic Moat
Loading...
Earnings Call
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about SNDX?
Bearish
Neutral
Bullish
Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Syndax Pharmaceuticals Inc

Current Assets 529.8m
Cash & Short-Term Investments 454.2m
Receivables 43.1m
Other Current Assets 32.6m
Non-Current Assets 22m
Long-Term Investments 20.1m
PP&E 1.6m
Other Non-Current Assets 217k
Current Liabilities 114.2m
Accounts Payable 13.8m
Accrued Liabilities 70.7m
Other Current Liabilities 29.7m
Non-Current Liabilities 322.2m
Long-Term Debt 321m
Other Non-Current Liabilities 1.2m
Efficiency

Free Cash Flow Analysis
Syndax Pharmaceuticals Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Syndax Pharmaceuticals Inc

Revenue
111.6m USD
Cost of Revenue
-5.1m USD
Gross Profit
106.5m USD
Operating Expenses
-413m USD
Operating Income
-306.5m USD
Other Expenses
-4.9m USD
Net Income
-311.4m USD
Fundamental Scores

SNDX Profitability Score
Profitability Due Diligence

Syndax Pharmaceuticals Inc's profitability score is 21/100. The higher the profitability score, the more profitable the company is.

ROIC is Increasing
Exceptional Gross Margin
Sustainable 3Y Average Gross Margin
Declining Net Margin
21/100
Profitability
Score

Syndax Pharmaceuticals Inc's profitability score is 21/100. The higher the profitability score, the more profitable the company is.

SNDX Solvency Score
Solvency Due Diligence

Syndax Pharmaceuticals Inc's solvency score is 46/100. The higher the solvency score, the more solvent the company is.

Short-Term Solvency
Negative Net Debt
Long-Term Solvency
High D/E
46/100
Solvency
Score

Syndax Pharmaceuticals Inc's solvency score is 46/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

SNDX Price Targets Summary
Syndax Pharmaceuticals Inc

Wall Street analysts forecast SNDX stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for SNDX is 40.09 USD with a low forecast of 27.27 USD and a high forecast of 58.8 USD.

Lowest
Price Target
27.27 USD
31% Upside
Average
Price Target
40.09 USD
92% Upside
Highest
Price Target
58.8 USD
182% Upside
View Analyst Estimates
View Analyst Estimates

Dividends

Syndax Pharmaceuticals Inc
does not pay dividends
Shareholder Yield

Current shareholder yield for SNDX is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Competitive Landscape

Company Market Cap Intrinsic Valuation Profitability Solvency Price Change
1Y 3Y 5Y

Ownership

SNDX Insider Trading
Buy and sell transactions by insiders

SNDX News

Other Videos
What is the Intrinsic Value of one SNDX stock?

The intrinsic value of one SNDX stock under the Base Case scenario is 27.5 USD.

Is SNDX stock undervalued or overvalued?

Compared to the current market price of 20.88 USD, Syndax Pharmaceuticals Inc is Undervalued by 24%.

Back to Top